The prevalence of hypertension is 22.7 percent among young adults aged 18 to 39 years and 5.4 percent among youth aged 8 to 19 years.

The Clinical Trials Program at Sidra Medicine will focus on clinical trials that will benefit children in the Arab region, particularly those withrare diseases that lack effective treatment.This ...

18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on ... target for treating HCC. Clinical data with irpagratinib ...

The poster, #983P, was presented at the Hepatocellular ... The FGFR4 signaling pathway is a recognized and promising target for treating HCC. Clinical data with irpagratinib have demonstrated ...

"An antibiotic allergy label has a significant impact on the clinical care of children that come into hospital, and this is exacerbated when the child comes in under the microbial stewardship ...

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for ...

18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16 ... recognized and promising target for treating HCC.

SHANGHAI, Sept. 19, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for the ...

This relaxes the blood vessels to reduce hypertension (high blood pressure). CCBs can be used in combination with other medications to lower blood pressure. This vasodilatory (widening the arteries) ...

The Montreal Children’s Hospital is doubling the number of cancer clinical trials for children and teens. It’s being offered over a five-year span, after receiving a large donation on Wednesday. In ...